Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD and Autonomic Function in Healthy Adults
NCT04731779Phase 1Completed
- Sponsor
- Castleton University
- Start
- Aug 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol in cardiovascular disease (CVD) (4 arms), sponsored by Castleton University. Primary endpoints: Standard deviation of RR intervals at 4 weeks, Root mean square of successive differences at 4 weeks and 5 more. Started Aug 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT04731779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04731779.